News

The complaint filed by the U.S. Department of Justice sought the permanent injunction against the company and its owners for manufacturing dietary supplements under conditions that do not

Under the multinational, double-blind placebo-controlled Phase III HERCULES study, the company will enroll 92 patients at clinical sites across 17 countries. The primary endpoint of the study is

GvHD is a complication that can occur after a stem cell or bone marrow transplant. The newly transplanted donor cells attack the transplant recipient’s body. Under the new

About $29.5m will support studies on caring for people affected with hepatitis C virus (HCV). Awards totaling around $7.4m will fund research on rare conditions in response to

The deal will allow Lilly and its German partner, Boehringer Ingelheim, to launch the product in the US in late 2016. Basaglar secured approval from the US Food

In August, NYBC announced a partnership with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for the repair and

The company worked with the US and European regulators to carry out its pivotal study under one global protocol for evaluating safety and efficacy of VTS-270. Vtesse will

Each year, there are approximately 1,500 new cases of MCC diagnosed in the US. Avelumab (also referred to as MSB0010718C) is an investigational fully human monoclonal IgG1 antibody

Opdivo is the first anti PD-1 (programmed death-1) approved to treat previously untreated cases of BRAF V600 wild-type unresectable or metastatic melanoma in adults. The approval was made